-
Clinical Ophthalmology
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Interferons and their potential in the treatment of ocular inflammation
(602) Article views
Authors: Friederike Mackensen, Regina Max, Matthias D Becker
Published Date October 2009 , Volume 2009:3
Friederike Mackensen,1 Regina Max,2 Matthias D Becker3
1Department of Ophthalmology, 2Department of Internal Medicine, Interdisciplinary Uveitis Center, University of Heidelberg, Germany; 3Department of Ophthalmology, Triemli Hospital Zürich, Switzerland
Abstract: Since their discovery in the 1950s interferons have been the scope of investigation in many diseases as therapeutic as well as pathogenetic factors. We know they have immune stimulatory and immune regulatory effects. This apparently counter-intuitive mechanism can be summarized as immunomodulatory action and seems to be very effective in a number of ocular inflammatory diseases. We review the current knowledge of interferons in immunity and autoimmunity and show their use in clinical ophthalmologic practice.
Keywords: interferon, uveitis, treatment, inflammation
- Display new articles on your site
Use our widget to show articles on your own site
- Journal Indexing
See where all the Dove Press journals are indexed
